Absolute Investment Advisers’s abrdn Life Sciences Investors HQL Stock Holding History

Absolute Investment Advisers’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-35,755	Closed	-$582K	–	123
2026 Q1	$582K	Buy	+35,755	New	+$598K	0.07%	113
2025 Q2	–	Sell	-192,378	Closed	-$2.44M	–	121
2025 Q1	$2.44M	Sell	192,378 -207,148	-52%	-$2.81M	0.36%	79
2024 Q4	$5.24M	Sell	399,526 -141,877	-26%	-$2.05M	0.67%	72
2024 Q3	$8.16M	Sell	541,403 -21,816	-4%	-$330K	1.11%	39
2024 Q2	$7.98M	Sell	563,219 -35,189	-6%	-$476K	1.18%	39
2024 Q1	$8.16M	Buy	+598,408	New	+$8.28M	1.11%	41

Other funds holding HQL

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

NIM

Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Absolute Investment Advisers's HQL Position: Q2 2026 in Review

Absolute Investment Advisers sold out of abrdn Life Sciences Investors (HQL) in Q2 2026, closing a stake of 35,755 shares — an estimated $582K sold.

Absolute Investment Advisers first reported a position in HQL in Q1 2024 and held it in 6 quarters. The position peaked at $8.16M in Q3 2024. 83 funds tracked by Wall St. Rank hold HQL as of Q2 2026.

Absolute Investment Advisers reported no remaining abrdn Life Sciences Investors position as of Q2 2026 after selling out during the quarter.
Absolute Investment Advisers sold 35,755 abrdn Life Sciences Investors shares in Q2 2026, an estimated $582K.
Absolute Investment Advisers first reported a position in abrdn Life Sciences Investors in Q1 2024 and held it in 6 quarters.
Absolute Investment Advisers's abrdn Life Sciences Investors position peaked at $8.16M in Q3 2024.
83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.

Based on Absolute Investment Advisers's 13F filing for Q2 2026, filed 21 Jul 2026.